BACK

Hetal Vora

Hetal Vora

Executive Director

Mumbai Office  |  hetal.vora@torreya.com   |   +91 98-2079-0795

Hetal, an Executive Director in Torreya’s Mumbai office, has over thirteen years in M&A, business finance, investment banking and credit risk.

Hetal joined Torreya in 2018 after 5 years within the M&A function of Hindustan Unilever Ltd , one of India’s largest FMCG companies. Prior to that, Hetal worked in diverse credit and equity analyst roles with organizations such as UBS, Edelweiss Capital, and Principal Mutual fund, amongst others.

Notable recent transactions that Hetal has worked on include the acquisition of Indulekha brand for HUL and divestment of several non-strategic business for the company.

Hetal is a trustee member of VYF, a non-profit organization which works with under privileged children.

Hetal earned her B.com in commerce from NM College of Commerce & Economics, Mumbai University. She is also a member of the Association of Chartered Financial Accountants (UK). Hetal is fluent in English and Hindi.

Selected Transactions

Marksans
Acquisition of bulk formulation manufacturing facility from
Teva India
October 2022
Accumax
Investment by
Creador_Invascent
$68 million
June 2022
Yapan Bio
Investment by
Piramal Pharma Solutions
December 2021
Zydus
Sale of domestic brands to
Integrace
September 2021
Relisys
Investment by
Siguler Guff
$13.5 million
August 2021
Biological E
Acquisition of Akorn India Limited, a subsidiary of
Akorn
August 2020
Glenmark
collaboration for its gynecological business in Nepal and India with
Integrace
January 2020